ACAD Short Positions, Funds Shorting ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc.
MX ˙ BMV ˙ US0042251084
Funds Shorting ACADIA Pharmaceuticals Inc.

This page shows institutions, funds, and major shareholders that have reported short positions in their last reporting period. We consider put option positions to be short positions and include all institutions that have disclosed put options here. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Upgradeto unlock premium data.

File Date Source Investor Type Avg Price
(Est)
Shares Δ Shares
(%)
Reported
Value
($1000)
Δ Value
(%)
Port Alloc
(%)
2025-03-18 13F/A Bank Of America Corp /de/ Put 0 -100.00 0 -100.00
2025-08-14 13F Jane Street Group, Llc Put 12,000 -9.09 259 17.81
2025-08-11 13F Citigroup Inc Put 59,900 100.33 1,292 160.48
2025-08-05 13F Simplex Trading, Llc Put 10,800 -65.93 0
2025-08-18 13F/A Nomura Holdings Inc Put 24,100 520
2025-08-27 13F/A Squarepoint Ops LLC Put 0 -100.00 0 -100.00
2025-08-14 13F Caption Management, LLC Put 30,000 50.00 647 94.88
2025-08-14 13F Susquehanna International Group, Llp Put 52,800 -32.05 1,139 -11.78
2025-08-14 13F Citadel Advisors Llc Put 65,100 7.96 1,404 40.26
2025-08-12 13F Proequities, Inc. Put 0 0
2025-08-14 13F Goldman Sachs Group Inc Put 89,800 0.00 1,937 29.85
2025-05-15 13F J. Goldman & Co LP Put 0 -100.00 0 -100.00
2025-08-14 13F Group One Trading, L.p. Put 17,400 114.81 375 179.85
Other Listings
DE:DR6 €21.73
GB:0A4W
US:ACAD $25.26
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista